These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8501181)

  • 41. A randomized, double-blind trial of a gonadotropin releasing-hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri.
    Friedman AJ; Barbieri RL; Doubilet PM; Fine C; Schiff I
    Fertil Steril; 1988 Mar; 49(3):404-9. PubMed ID: 2963759
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gonadotrophin hormone-releasing hormone analogue treatment of fibroids.
    Shaw RW
    Baillieres Clin Obstet Gynaecol; 1998 Jun; 12(2):245-68. PubMed ID: 10023421
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multiple therapies for vaginal bleeding secondary to large uterine myomas.
    Thomas MA; Gass ML; Scott MC; Liu JH
    Int J Gynaecol Obstet; 1991 Nov; 36(3):239-41. PubMed ID: 1685460
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gonadotropin-releasing hormone agonist use before hysterectomy.
    Stovall TG; Summit RL; Washburn SA; Ling FW
    Am J Obstet Gynecol; 1994 Jun; 170(6):1744-8; discussion 1748-51. PubMed ID: 8203435
    [TBL] [Abstract][Full Text] [Related]  

  • 45. D-Trp-6-luteinizing hormone-releasing hormone microcapsules in the treatment of uterine leiomyomas.
    Golan A; Bukovsky I; Schneider D; Ron-el R; Herman A; Caspi E
    Fertil Steril; 1989 Sep; 52(3):406-11. PubMed ID: 2528476
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Triptorelin to prevent hysterectomy in patients with leiomyomas.
    van Leusden HA
    Lancet; 1988 Aug; 2(8609):508. PubMed ID: 2900426
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effect of decapeptyl (D-TrpG GnPh) on estrogen receptors, progesterone receptors and tissue levels of estrogens (non-conjugated and sulfate-conjugated) in patients with uterine myoma].
    Pasqualini JR; Cornier E; Grenier J; Vella C; Schatz B; Netter A
    Pathol Biol (Paris); 1990 Nov; 38(9):941-3. PubMed ID: 2148976
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of Decapeptyl, an agonistic analog of gonadotropin-releasing hormone on estrogens, estrogen sulfates, and progesterone receptors in leiomyoma and myometrium.
    Pasqualini JR; Cornier E; Grenier J; Vella C; Schatz B; Netter A
    Fertil Steril; 1990 Jun; 53(6):1012-7. PubMed ID: 2140991
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment with a gonadotrophin releasing hormone agonist before hysterectomy for leiomyomas: results of a multicentre, randomised controlled trial.
    Vercellini P; Crosignani PG; Mangioni C; Imparato E; Ferrari A; De Giorgi O
    Br J Obstet Gynaecol; 1998 Nov; 105(11):1148-54. PubMed ID: 9853762
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An evidence-based approach to hormonal therapies for premenopausal women with fibroids.
    Lethaby AE; Vollenhoven BJ
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):307-31. PubMed ID: 17905660
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Three-month treatment with triptorelin, letrozole and ulipristal acetate before hysteroscopic resection of uterine myomas: prospective comparative pilot study.
    Bizzarri N; Ghirardi V; Remorgida V; Venturini PL; Ferrero S
    Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():22-6. PubMed ID: 26142912
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predictors of uterine volume reduction in women with myomas treated with a gonadotropin-releasing hormone agonist.
    Friedman AJ; Daly M; Juneau-Norcross M; Rein MS
    Fertil Steril; 1992 Aug; 58(2):413-5. PubMed ID: 1633911
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A randomized, placebo-controlled, double-blind study evaluating leuprolide acetate depot treatment before myomectomy.
    Friedman AJ; Rein MS; Harrison-Atlas D; Garfield JM; Doubilet PM
    Fertil Steril; 1989 Nov; 52(5):728-33. PubMed ID: 2509250
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Obesity and GnRH action. Report of a case with contribution by peripherally derived estrogens.
    Hansen LM; Batzer FR; Corson SL; Bello S
    J Reprod Med; 1997 Apr; 42(4):247-50. PubMed ID: 9131500
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gonadotropin-releasing hormone agonist plus add-back sex steroids to reduce risk of breast cancer.
    Spicer D; Shoupe D; Pike M
    J Natl Cancer Inst; 1991 Dec; 83(23):1763. PubMed ID: 1770556
    [No Abstract]   [Full Text] [Related]  

  • 56. Depot GnRH analog treatment of uterine fibroids.
    Loverro G; Nicolardi V; Selvaggi L
    Int J Gynaecol Obstet; 1993 Nov; 43(2):199-201. PubMed ID: 7905441
    [No Abstract]   [Full Text] [Related]  

  • 57. The combined effect of a GnRH analog in premenopause plus postmenopausal estrogen deficiency for the treatment of uterine leiomyomas in perimenopausal women.
    de Aloysio D; Altieri P; Pretolani G; Romeo A; Paltrinieri F
    Gynecol Obstet Invest; 1995; 39(2):115-9. PubMed ID: 7737580
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Uterine adenocarcinoma after GnRH agonist treatment.
    Dessole S; Ruiu GA; Cherchi PL; Ambrosini G
    Arch Gynecol Obstet; 2000 Feb; 263(3):148-9. PubMed ID: 10763848
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [GnRH-analogs in the therapy of uterine myomatosis].
    Wieacker P; Geisthövel F; Adelberger V; Breckwoldt M
    Ther Umsch; 1990 Dec; 47(12):951-7. PubMed ID: 2151405
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Morphologic patterns of human endometrial epithelium in women with uterine myomata treated with leuprorelin acetate.
    Palmara V; Triolo O; Benedetto V; Lo Re C; Sturlese E; Retto G; Santoro G
    Gynecol Obstet Invest; 2010; 69(2):131-5. PubMed ID: 19996602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.